Prostate Specific Membrane Antigen
Showing 26 - 50 of >10,000
Prostate-Specific Membrane Antigen PET Scans in People Prostate
Recruiting
- Prostate Cancer
- +4 more
- 18F-DCFPyL-iPSMA
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 29, 2022
Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)
Not yet recruiting
- Medullary Thyroid Cancer
- +3 more
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Sep 8, 2022
Positron Emission Radiomics With PSMA Radioligands on Newly
Not yet recruiting
- Prostate Cancer
- Immunohistochemistry (IHC) analysis
- (no location specified)
Apr 6, 2023
Prostate Cancer Trial in Vienna (PSMA PET Scan, FDHT PET Scan)
Recruiting
- Prostate Cancer
- PSMA PET Scan
- FDHT PET Scan
-
Vienna, AustriaMedical University of Vienna
Oct 25, 2021
Prostate Cancer Trial in San Francisco (CTT1403, CTT1057, 68Ga-PSMA-11)
Active, not recruiting
- Prostate Cancer
- CTT1403
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 14, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.11GBq of 177Lu-EB-PSMA-617
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 6, 2022
Prostate Cancer Patients Treated With Lutetium - Prostate
Recruiting
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- WB-MRI
-
Meldola, Forlì-Cesena, Italy
- +1 more
Jan 12, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023
Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,
Active, not recruiting
- Adenocarcinoma of the Prostate
- +3 more
- anti-PSMA monoclonal antibody MDX1201-A488
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Metastatic Prostate Adenocarcinoma Trial in New York (68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator)
Completed
- Metastatic Prostate Adenocarcinoma
- 68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator
-
New York, New YorkWeill Cornell Medicine
Feb 1, 2022
Thyroid Gland Carcinoma Trial in San Francisco (Gallium Ga 68-labeled PSMA-11, Magnetic Resonance Imaging, Positron Emission
Terminated
- Thyroid Gland Carcinoma
- Gallium Ga 68-labeled PSMA-11
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 25, 2021
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Recruiting
- Prostate Adenocarcinoma
- +2 more
- MRI-guided Intensity-Modulated Radiation Therapy
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023
68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer
Completed
- PET/CT
- +2 more
- total-body PET/CT
-
Shanghai, Shanghai, ChinaShanghai jiaotong University School of Medicine, Renji Hospital
Nov 15, 2021
Prostate Cancer Trial in Chandigarh (Robotic arm assisted PSMA PET/CT guided prostate biopsy)
Completed
- Prostate Cancer
- Robotic arm assisted PSMA PET/CT guided prostate biopsy
-
Chandigarh, Chandīgarh, IndiaDepartment of Nuclear Medicine, PGIMER
Aug 20, 2021
Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging
Completed
- Stage II Prostate Adenocarcinoma
- Stage III Prostate Adenocarcinoma
- 68Ga-PSMA-11
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Mar 2, 2022
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Malignant Tumor Trial in Wuhan (68Ga-PSMA, PET/MR, PET/CT)
Recruiting
- Malignant Neoplasm
- 68Ga-PSMA
- +2 more
-
Wuhan, Hubei, ChinaChina, Hubei Province
Feb 9, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- 68Ga-PSMA-11
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California San Francisco
Feb 27, 2022
Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City
Not yet recruiting
- Stage IIC Prostate Cancer AJCC v8
- +2 more
- Biospecimen Collection
- +9 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 3, 2023
Prostate Cancer Trial in Zurich ([68Ga]PSMA-11, [18F]PSMA-1007)
Completed
- Prostate Cancer
-
Zurich, SwitzerlandUniversity Hospital Zurich
Aug 27, 2021
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta
Not yet recruiting
- Castration-Sensitive Prostate Carcinoma
- +2 more
- Abiraterone
- +9 more
-
Atlanta, Georgia
- +1 more
Feb 8, 2023
High Risk Prostate Cancer Trial in Turku (Whole body contrast enhanced computer tomography, 99mTC-HMDP planar bone scintigraphy
Completed
- High Risk Prostate Cancer
- Whole body contrast enhanced computer tomography
- +4 more
-
Turku, FinlandDepartment of Urology
May 3, 2022